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PreviewsTh9 cells. The Th2 cell lineage-deter-
mining events, Stat6 signaling and
Gata3 expression, seem a developmental
requirement for Th9 cells. The combina-
tional expression of both IRF4 and PU.1
could thus be instrumental in (re)program-
ming classical Th2, inhibiting IL-4, IL-5,
IL-6, and IL-13 and inducing IL-9 while
maintaining IL-10 (Figure 1).
The abundance of IRF4 interacting
partners, determining its DNA binding
interactions and its functioning as either
a transcriptional activator or repressor,
suggests that its interactions in different
cell types and its level of expression may
be more important than the presence of
IRF4 in itself.REFERENCES
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The endogenous lipids that control the functions of invariant natural killer T (iNKT) cells remain enigmatic.
In this issue of Immunity, Darmoise et al. (2010) report that lysosomal a-galactosidase A destroys self-anti-
gens recognized by iNKT cells.Autoreactivity in the adaptive immune
system is normally curtailed by rigorous
selection processes in central lymphoid
organs, followed by tolerance mecha-
nisms in the periphery. However, some
populations of lymphocytes appear to
require at least some level of autoreactiv-
ity in order to effectively dispatch their
effector functions. These cells largely
carry out functions related to the detec-
tion of self-ligands that are induced in
injured or stressed tissues. Invariant
natural killer T (iNKT) cells belong to this
family of innate lymphocytes that exhibit
natural autoreactivity. iNKT cells are
specific for lipid antigens bound by the
MHC class I-related protein CD1d. These
cells express a semi-invariant T cell
receptor (TCR) (Va14-Ja18 in mice or
Va24-Ja18 in humans) together with
lineage markers of natural killer (NK) cells.Following TCR engagement, iNKT cells
rapidly elicit their effector functions to
generate protective immunity against
pathogens and tumors and to suppress
autoimmunity. Several foreign lipid anti-
gens that can activate iNKT cells have
been identified, including the marine
sponge-derived glycosphingolipid a-gal-
actosylceramide that is commonly em-
ployed to study iNKT cells. However, the
natural self-antigens that mediate iNKT
cell autoreactivity remain enigmatic, and
their identity is hotly debated (Gapin,
2010). A provocative study by Darmoise
et al. (2010) in this issue of Immunity
provides evidence that the lysosomal
enzyme a-galactosidase A (a-Gal-A)
controls the generation of self-antigens
for iNKT cells.
The hunt for natural iNKT cell antigens
has taken several twists and turns. Aninitial study with a cell line deficient in
b-glucosylceramide synthase pointed
toward glycosphingolipids as natural
ligands of iNKT cells (Stanic et al., 2003).
A subsequent study demonstrated
defective iNKT cell development in mice
lacking the b-hexosaminidase A and B
(b-Hex-AB) enzymes, which participate
in the degradation of glycosphingolipids
in lysosomes (Zhou et al., 2004). Isoglobo-
trihexosylceramide (iGb3) was identified
as a natural self-antigen by investigating
the capacity of various products of this
pathway to activate iNKT cells. However,
subsequent studies cast doubt on iGb3
as the sole endogenous antigen respon-
sible for iNKT cell development because
conventional biochemical and mass
spectrometry techniques were unable to
identify iGb3 in lymphoid tissues, mice
deficient in iGb3 synthase exhibited, August 27, 2010 ª2010 Elsevier Inc. 143
Figure 1. Proposed Role of the Lysosomal Enzyme a-Gal-A in the Biogenesis of Self-
Antigens for iNKT Cells
Based on the studies by Darmoise et al. (2010), a proposed mechanism for the autoreactivity of iNKT cells
against wild-type DCs (left panel), DCs from Fabry mice (middle panel), and wild-type DCs stimulated with
microbes or their products (right panel) is depicted. Red arrows denote signaling events, and the blue
arrow denotes reduced enzymatic activity of a-Gal-A. LTP, lipid transfer protein; sPRR, signaling
pattern-recognition receptor.
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Previewsnormal iNKT cell development and func-
tion, and the human iGb3 synthase gene
appeared to be nonfunctional (Gapin,
2010). Further, mice with diverse lipid
storage disorders were found to contain
defects in iNKT cell development (Gadola
et al., 2006), raising the possibility that the
iNKT cell defect in b-Hex-AB-deficient
mice might be related to general glyco-
lipid overload of endolysosomal compart-
ments. Nevertheless, since then, highly
sensitive mass spectrometry techniques
have been able to identify iGb3 in mouse
and human thymus (Li et al., 2009).
What would happen if natural self-
antigens of iNKT cells were enriched
in antigen-presenting cells (APCs)? Dar-
moise et al. (2010) found that iNKT cells
strongly react to APCs from a-Gal-A-defi-
cient mice (Figure 1, middle panel), a
mouse model for human Fabry disease.
a-Gal-A degrades iGb3 (as well as Gb3)
to lactosylceramide, and a-Gal-A defi-
ciency would therefore be expected to
cause an accumulation of iGb3, Gb3,
and possibly other glycolipids (Figure 1,
middle panel). Consistent with this possi-
bility, a previous study showed that iGb3144 Immunity 33, August 27, 2010 ª2010 Elswas enriched approximately 5-fold in the
thymus of Fabry mice (Li et al., 2009).
Darmoise et al. (2010) further showed
that dendritic cells (DCs) from these
animals had increased levels of Gb3.
They found that DCs from Fabry mice or
DCs from wild-type mice treated with
the a-Gal-A inhibitor 1-deoxygalactonojir-
imycin potently stimulated both primary
iNKT cells and derived hybridomas in the
absence of alterations in surface CD1d
expression. This finding was somewhat
surprising because prior studies with total
splenocytes or thymocytes from Fabry
mice found no effect on iNKT cell activa-
tion. Darmoise et al. (2010) employed
DCs, so perhaps this pathway ismost crit-
ical in professional APCs.
Is the phenotype of DCs from Fabry
mice caused by general glycolipid over-
load rather than the specific enzymatic
activity of a-Gal-A? This is unlikely
because APCs from other mice with
defects in glycolipid storage exhibited
normal or reduced capacity to activate
iNKT cells, whereas DCs from Fabry
mice demonstrated a gain of function
with regard to iNKT cell activation. Con-evier Inc.sistent with the notion that the alterations
in DCs from Fabry mice were because of
accumulation of iNKT cell antigens rather
than a nonspecific mechanism, Darmoise
et al. (2010) showed that DCs from these
animals behaved similarly to DCs from
wild-type mice with respect to antigen
presentation to conventional T cells, ex-
pression of costimulatory molecules,
IL-12 production in response tomicrobes,
and lipid raft organization.
The increased capacity of a-Gal-A-defi-
cient DCs to activate iNKT cells was not
just an in vitro phenomenon because
adoptive transfer of DCs from Fabry
mice into wild-type animals resulted in
profound iNKT cell activation (Darmoise
et al., 2010). Conversely, iNKT cells from
wild-type mice proliferated extensively
upon adoptive transfer into Fabry mice.
Therefore, these findings are consistent
with the hypothesis that DCs from Fabry
mice express increased levels of natural
self-antigens for iNKT cells. The possi-
bility that iGb3 might be a relevant self-
antigen was supported by inhibitor
studies: long-term culture of DCs from
Fabry mice with the b-glucosylceramide
synthase inhibitor N-butyl-1-deoxygalac-
tonojirimycin, or short-term pretreatment
with isolectin B4, which binds to terminal
a-linked digalactose residues in glyco-
conjugates such as iGb3, abolished the
increased iNKT cell activation.
The autoreactivity of iNKT cells plays
a critical role in the response of these cells
to microorganisms (Gapin, 2010). Most
microbes activate iNKT cells indirectly
by engaging signaling pattern-recognition
receptors on DCs that induce the produc-
tion of proinflammatory cytokines (Fig-
ure 1, right panel). This activation typically
also involves interaction of the invariant
TCR with CD1d, suggesting synergistic
interactions between cytokine- and
TCR-mediated signals. It has been shown
that microbial products can alter CD1d-
associated lipid profiles (e.g., Muindi
et al., 2010), and a role of iGb3 in acti-
vating iNKT cells during microbial infec-
tions has been suggested (Mattner et al.,
2005). Darmoise et al. (2010) found that
culture of DCs from Fabry mice with
microorganisms or their products caused
increased iNKT cell activation. More
importantly, they further showed that
treatment of wild-type DCs with microor-
ganisms or their products caused a
transient decrease (up to about 50%) in
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Previewsa-Gal-A enzyme activity. Therefore, these
findings suggested that microbial activa-
tion of DCs leads to an accumulation of
glycolipids that are normally degraded
by a-Gal-A (Figure 1, right panel). Inhibitor
studies further suggested that iGb3 could
well be a relevant glycolipid in this
context.
The idea that iGb3 might be the sole
antigen that controls the intrathymicdevel-
opment of iNKTcells is particularly conten-
tious (Gapin, 2010). Darmoise et al. (2010)
were unable to identify a defect in intrathy-
mic development of iNKT cells in Fabry
mice, which is consistent with some, but
not all, prior studies (e.g., Gadola et al.,
2006). Nevertheless, they found that
numbers of peripheral iNKT cells in these
animals were substantially suppressed,
which they attributed to increased death
because of chronic activation in the
periphery. Consistent with this possibility,
the remaining iNKT cells in Fabry mice ex-
hibited a hyporesponsive phenotypewhen
stimulated with a-galactosylceramide,
which was associated with increased
expression of inhibitory NK cell receptors.
Is this pathway for the generation of
endogenous iNKT cell antigens in mice
conserved in humans? Probably not.
Studies with human iNKT cell clones
have failed to find a role for the CD1drecycling pathway (see Figure 1) in the
autoreactivity of these cells (Chen et al.,
2007). Further, as mentioned above,
although ultrasensitive mass spectrom-
etry studies were able to identify iGb3 in
human thymus, the iGb3 synthase gene
in humans appears to be defective. Lastly,
patients with Fabry disease have normal
numbers of iNKT cells.
As with most provocative studies, the
paper from Darmoise et al. (2010) raises
more questions than it answers: What are
the relevant iNKT cell self-antigens that
accumulate in Fabrymice? Is the accumu-
lation of iNKT cell antigens in Fabry mice
unique to DCs, or does this also occur in
other cell types such as the cells that
mediate thymic selection of iNKT cells?
What controls the transient inactivation of
a-Gal-A enzyme activity in DCs stimulated
with microbial products? How might the
relatively modest suppression of a-Gal-A
activity in response to microbes mediate
such a profound effect on iNKT cell activa-
tion? Do the relevant self-antigens that
accumulate in Fabry mice contribute to
other pathological conditions that are
influenced by iNKT cells? To what extent,
if at all, is this pathway conserved in
humans? Providing answers to these
questions will likely keep iNKT cell biolo-
gists busy for the coming years.Immunity 33REFERENCES
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The interaction between different transcriptional pathways in CD8+ T cell memory remains incompletely
understood. In this issue, Zhou et al. (2010) demonstrate an important role for T cell factor 1 in regulating
CD8+ T cell memory via control of a second transcription factor, Eomesodermin.There are clear parallels between the de-
velopment of adaptive immune responses
and other developmental systems. The
Wnt-b-catenin pathway is important in
many of these development processes.
Although canonical Wnt signaling has a
role in thymic development and has been
reported to influence CD8+ T cell memory(Zhao et al., 2010), precisely how this
morphogenic signaling pathway is linked
to the transcriptional regulation of T cell
memory has remained unclear. Normally,
in the absence of Wnt ligands, b-catenin
is sequestered and rapidly degraded in
the cytoplasm. Wnt signaling stabilizes
b-catenin, allowing translocation to thenucleus and interaction with T cell factor 1
(TCF-1). b-catenin displaces TLE1, aGrou-
cho family corepressor bound to TCF-1,
converting the repressive TCF-1-TLE1
complex into a TCF-1-b-catenin transcrip-
tional activator (MacDonald et al., 2009).
In this issue, Zhou et al. (2010)
demonstrate that TCF-1 activation by, August 27, 2010 ª2010 Elsevier Inc. 145
